Medicine Description cidophage-retard 850mg
Cidophage Retard is a medication that combines glibenclamide and metformin to effectively manage hyperglycemia in individuals with type 2 diabetes. Glibenclamide is a sulfonylurea that stimulates the pancreas to release more insulin, thereby lowering blood glucose levels. It enhances insulin secretion in response to glucose, particularly after meals. Metformin, on the other hand, primarily works by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues, particularly muscle and fat. This dual-action approach not only helps regulate blood sugar levels but also addresses insulin resistance, making it a comprehensive treatment option for type 2 diabetes.
Indications and Uses of Cidophage Retard
- Management of blood glucose levels in adults with type 2 diabetes when diet and exercise alone do not achieve adequate control.
- Used as an adjunct therapy in combination with insulin or other antidiabetic agents when necessary.
- Indicated for patients with insulin resistance.
Side Effects of Cidophage Retard
- Hypoglycemia, particularly when combined with other antidiabetic medications.
- Gastrointestinal disturbances, including nausea, vomiting, and diarrhea.
- Abdominal discomfort and flatulence.
- Potential for lactic acidosis, especially in patients with renal impairment.
- Skin reactions such as rashes.
Storage and Handling
Store Cidophage Retard at room temperature, away from moisture and heat. Keep out of reach of children and ensure the medication is securely closed to prevent contamination.
Patient Advice and Precautions
Monitor blood sugar levels regularly to assess the effectiveness of the therapy. Always follow dietary recommendations and exercise routines suggested by your healthcare provider. Report any unusual symptoms such as persistent nausea, abdominal pain, or signs of hypoglycemia immediately. It’s crucial to inform your doctor about all other medications being taken to avoid potential drug interactions.